Cargando…
Candesartan could ameliorate the COVID-19 cytokine storm
BACKGROUND: Angiotensin receptor blockers (ARBs) reducing inflammation and protecting lung and brain function, could be of therapeutic efficacy in COVID-19 patients. METHODS: Using GSEA, we compared our previous transcriptome analysis of neurons injured by glutamate and treated with the ARB Candesar...
Autores principales: | Elkahloun, Abdel G., Saavedra, Juan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439834/ https://www.ncbi.nlm.nih.gov/pubmed/32942152 http://dx.doi.org/10.1016/j.biopha.2020.110653 |
Ejemplares similares
-
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease
por: Elkahloun, Abdel G., et al.
Publicado: (2016) -
Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?
por: Vignesh, Ramachandran, et al.
Publicado: (2021) -
Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19
por: Manayi, Azadeh, et al.
Publicado: (2021) -
Evaluation of Ameliorative Effect of Quercetin and Candesartan in Doxorubicin-Induced Cardiotoxicity
por: Majhi, Sagarika, et al.
Publicado: (2022) -
Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?
por: Vignesh, Ramachandran, et al.
Publicado: (2021)